Institutional investors purchased a net $153.7 thousand shares of DEPO during the quarter ended September 2017 and now own 92.72% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 2.2 Million shares of Depomed Inc
MILLENNIUM MANAGEMENT LLC Bought 888.6 Thousand shares of Depomed Inc
RENAISSANCE TECHNOLOGIES LLC Bought 820.8 Thousand shares of Depomed Inc